Nucleai’s vision is to bring spatial biology to the forefront of precision medicine and embed its platform in every clinical trial involving tissue.

The Nucleai team will have access to Sheba Medical Center's extensive repository of pathology, clinical, and other multi-omics data.

Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.

From AI algorithms set to transform diagnoses to new urine and blood tests, these are the cancer-related developments so far this year